Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allavena

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1988
DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative responseM Di Bello, V Lucchini, S Chiari, et al.
International Journal of Cancer|July 15, 1987
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infectionB Macchi, M Popovic, P Allavena, et al.
European Journal of Immunology|March 1, 1991
Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cellsA Biondi, C Paganin, V Rossi, et al.
Cytotechnology|February 24, 2012
T-cell receptor gene rearrangements and expression in normal human large granular lymphocytes (LGL) and their pathological expansionsA Pirelli, P Allavena, A Rambaldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequencesN Polentarutti, P Allavena, G Bianchi, et al.
Journal of the National Cancer Institute|October 1, 1986
Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumorsP Allavena, F Zanaboni, S Rossini, et al.
International Journal of Cancer|April 22, 1992
Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapyN Colombo, F Peccatori, C Paganin, et al.
Scandinavian Journal of Immunology|February 1, 1986
Lymphokine production in T gamma lymphoproliferative disordersA Rambaldi, V Rossi, P Allavena, et al.
Blood|June 25, 1998
Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cellsG D'Amico, G Bianchi, S Bernasconi, et al.
Research in Immunology|May 1, 1993
Cytokine regulation of tumour-associated macrophagesA Mantovani, B Bottazzi, S Sozzani, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|January 1, 1988
DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative responseM Di Bello, V Lucchini, S Chiari, et al.
International Journal of Cancer|July 15, 1987
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infectionB Macchi, M Popovic, P Allavena, et al.
European Journal of Immunology|March 1, 1991
Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cellsA Biondi, C Paganin, V Rossi, et al.
Cytotechnology|February 24, 2012
T-cell receptor gene rearrangements and expression in normal human large granular lymphocytes (LGL) and their pathological expansionsA Pirelli, P Allavena, A Rambaldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequencesN Polentarutti, P Allavena, G Bianchi, et al.
Journal of the National Cancer Institute|October 1, 1986
Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumorsP Allavena, F Zanaboni, S Rossini, et al.
International Journal of Cancer|April 22, 1992
Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapyN Colombo, F Peccatori, C Paganin, et al.
Scandinavian Journal of Immunology|February 1, 1986
Lymphokine production in T gamma lymphoproliferative disordersA Rambaldi, V Rossi, P Allavena, et al.
Blood|June 25, 1998
Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cellsG D'Amico, G Bianchi, S Bernasconi, et al.
Research in Immunology|May 1, 1993
Cytokine regulation of tumour-associated macrophagesA Mantovani, B Bottazzi, S Sozzani, et al.
Pageof 15